Relative efficacy of glucarate on the initiation and promotion phases of rat mammary carcinogenesis. 1995

H Abou-Issa, and M Moeschberger, and W el-Masry, and S Tejwani, and R W Curley, and T E Webb
Department of Surgery, College of Medicine, Ohio State University, Columbus 43210, USA.

The independent effects of the potential cancer chemopreventive agent calcium glucarate (CGT) when fed (128 mmol/kg diet) during the initiation (I), promotion (P) or (I+P) phases of 7,12-dimethylbenzanthracene-induced rat mammary carcinogenesis, was compared to that of the known chemopreventive agent N-(4-hydroxyphenyl) retinamide (4-HPR) fed (2.0 mmol/kg diet) during these same phases. CGT and especially 4-HPR both significantly increased tumor latency when fed during the P-phase. When fed during I, P or I+P phases mammary tumor incidence was reduced compared to the controls 33%, 42% and 67% by 4-HPR and 18%, 42% and 50% by CGT. Similarly, tumor multiplicity was significantly reduced by either agent. For example, as compared to the corresponding control, when fed during the I, P or I+P phases 4-HPR reduced tumor multiplicity 63, 34 and 63%, while CGT reduced tumor multiplicity 28, 42 and 63% respectively. CGT, like 4-HPR, acts on both the I and P phases with the effect being maximal when fed during P and I+P phases.

UI MeSH Term Description Entries
D008325 Mammary Neoplasms, Experimental Experimentally induced mammary neoplasms in animals to provide a model for studying human BREAST NEOPLASMS. Experimental Mammary Neoplasms,Neoplasms, Experimental Mammary,Experimental Mammary Neoplasm,Mammary Neoplasm, Experimental,Neoplasm, Experimental Mammary
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D005260 Female Females
D005937 Glucaric Acid A sugar acid derived from D-glucose in which both the aldehydic carbon atom and the carbon atom bearing the primary hydroxyl group are oxidized to carboxylic acid groups. Glucosaccharic Acid,L-Gularic Acid,Levo-Gularic Acid,Tetrahydroxyadipic Acid,Calcium Glucarate,Calcium Glucarate, Anhydrous,Calcium Saccharate,Calcium Saccharate Anhydrous,Calcium Saccharate Tetrahydrate,Calcium Saccharate, Anhydrous,D-Glucaric Acid,D-Saccharic Acid,Saccharic Acid,Acid, Saccharic,Anhydrous Calcium Glucarate,Anhydrous Calcium Saccharate,D Glucaric Acid,D Saccharic Acid,Glucarate, Anhydrous Calcium,Glucarate, Calcium,L Gularic Acid,Levo Gularic Acid,Saccharate Tetrahydrate, Calcium,Saccharate, Anhydrous Calcium,Saccharate, Calcium,Tetrahydrate, Calcium Saccharate
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D015127 9,10-Dimethyl-1,2-benzanthracene Polycyclic aromatic hydrocarbon found in tobacco smoke that is a potent carcinogen. 7,12-Dimethylbenzanthracene,7,12-Dimethylbenz(a)anthracene,7,12 Dimethylbenzanthracene
D016588 Anticarcinogenic Agents Agents that reduce the frequency or rate of spontaneous or induced tumors independently of the mechanism involved. Anti-Carcinogenic Agents,Anti-Carcinogenic Drugs,Anti-Carcinogenic Effect,Anti-Carcinogenic Effects,Anticarcinogenic Drugs,Anticarcinogenic Effect,Anticarcinogenic Effects,Anticarcinogens,Agents, Anti-Carcinogenic,Agents, Anticarcinogenic,Anti Carcinogenic Agents,Anti Carcinogenic Drugs,Anti Carcinogenic Effect,Anti Carcinogenic Effects,Drugs, Anti-Carcinogenic,Drugs, Anticarcinogenic,Effect, Anti-Carcinogenic,Effect, Anticarcinogenic,Effects, Anti-Carcinogenic,Effects, Anticarcinogenic
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats
D017313 Fenretinide A synthetic retinoid that is used orally as a chemopreventive against prostate cancer and in women at risk of developing contralateral breast cancer. It is also effective as an antineoplastic agent. 4-HPR,4-Hydroxyphenylretinamide,Fenretinide, 13-cis-Isomer,Fenretinimide,MCN-R-1967,N-(4-Hydroxyphenyl)-trans-Retinamide,N-(4-Hydroxyphenyl)retinamide,13-cis-Isomer Fenretinide,4 Hydroxyphenylretinamide,Fenretinide, 13 cis Isomer,MCN R 1967,MCNR1967

Related Publications

H Abou-Issa, and M Moeschberger, and W el-Masry, and S Tejwani, and R W Curley, and T E Webb
January 1996, Anticancer research,
H Abou-Issa, and M Moeschberger, and W el-Masry, and S Tejwani, and R W Curley, and T E Webb
November 1981, Cancer research,
H Abou-Issa, and M Moeschberger, and W el-Masry, and S Tejwani, and R W Curley, and T E Webb
January 2003, JPEN. Journal of parenteral and enteral nutrition,
H Abou-Issa, and M Moeschberger, and W el-Masry, and S Tejwani, and R W Curley, and T E Webb
February 1988, Carcinogenesis,
H Abou-Issa, and M Moeschberger, and W el-Masry, and S Tejwani, and R W Curley, and T E Webb
January 2021, Annual review of medicine,
H Abou-Issa, and M Moeschberger, and W el-Masry, and S Tejwani, and R W Curley, and T E Webb
February 1987, Bollettino della Societa italiana di biologia sperimentale,
H Abou-Issa, and M Moeschberger, and W el-Masry, and S Tejwani, and R W Curley, and T E Webb
April 1988, Cancer research,
H Abou-Issa, and M Moeschberger, and W el-Masry, and S Tejwani, and R W Curley, and T E Webb
January 1987, Occupational medicine (Philadelphia, Pa.),
H Abou-Issa, and M Moeschberger, and W el-Masry, and S Tejwani, and R W Curley, and T E Webb
June 1979, Seminars in oncology,
H Abou-Issa, and M Moeschberger, and W el-Masry, and S Tejwani, and R W Curley, and T E Webb
January 1990, Cancer letters,
Copied contents to your clipboard!